Informações:
Falhas:
ID
26311
Descrição
The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00727948
Link
https://clinicaltrials.gov/show/NCT00727948
Palavras-chave
Versões (1)
- 16/10/2017 16/10/2017 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
16 de outubro de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Breast Cancer NCT00727948
Eligibility Breast Cancer NCT00727948
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00727948
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Breast Carcinoma
Item
histologically or cytologically proven breast cancer
boolean
C0678222 (UMLS CUI [1])
Premenopausal state | Postmenopausal state
Item
pre or post-menopausal
boolean
C0232969 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
C0232970 (UMLS CUI [2])
Age
Item
age >18
boolean
C0001779 (UMLS CUI [1])
Adjuvant therapy Completed | Exception Hormone Therapy | Operative Surgical Procedures Completed| Chemotherapy Completed | Therapeutic radiology procedure Completed
Item
completed adjuvant non-hormonal therapy >30 days prior to initiation of study (surgery and/or chemotherapy and/or radiation therapy)
boolean
C0677850 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0279025 (UMLS CUI [2,2])
C0543467 (UMLS CUI [3,1])
C0205197 (UMLS CUI [3,2])
C0392920 (UMLS CUI [4,1])
C0205197 (UMLS CUI [4,2])
C1522449 (UMLS CUI [5,1])
C0205197 (UMLS CUI [5,2])
C0205197 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0279025 (UMLS CUI [2,2])
C0543467 (UMLS CUI [3,1])
C0205197 (UMLS CUI [3,2])
C0392920 (UMLS CUI [4,1])
C0205197 (UMLS CUI [4,2])
C1522449 (UMLS CUI [5,1])
C0205197 (UMLS CUI [5,2])
Platelet Count measurement | Hemoglobin measurement
Item
platelet count and hemoglobin within normal ranges for local lab within 30 days of initiation of study therapy
boolean
C0032181 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
C0518015 (UMLS CUI [2])
Tamoxifen
Item
receiving tamoxifen therapy for at least 90 days prior to initiation of study therapy, and is expected to continue that therapy for the duration of the study (75 days)
boolean
C0039286 (UMLS CUI [1])
Chemotherapy Regimen | Therapeutic radiology procedure | Operative Surgical Procedures
Item
chemotherapy, radiation therapy or surgery within 30 days of study therapy
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C0543467 (UMLS CUI [3])
C1522449 (UMLS CUI [2])
C0543467 (UMLS CUI [3])
Aspirin | Antiplatelet Agents | Anticoagulants
Item
current use of aspirin, anti-platelet or anti-coagulation agents on a continuous basis
boolean
C0004057 (UMLS CUI [1])
C0085826 (UMLS CUI [2])
C0003280 (UMLS CUI [3])
C0085826 (UMLS CUI [2])
C0003280 (UMLS CUI [3])
Gastrointestinal Hemorrhage | Central nervous system haemorrhage | Blood in stool | Rectal hemorrhage
Item
prior history of gastrointestinal or central nervous system bleeding, or documented or self-reported blood in stools or bright red blood per rectum
boolean
C0017181 (UMLS CUI [1])
C3267019 (UMLS CUI [2])
C1321898 (UMLS CUI [3])
C0267596 (UMLS CUI [4])
C3267019 (UMLS CUI [2])
C1321898 (UMLS CUI [3])
C0267596 (UMLS CUI [4])